colorectal cancer
Conditions
Brief summary
Evaluation of the safety and feasibility, Increase in the rate of complete histopathological response in the treatment arm compared to the control arm.
Interventions
DRUGBLEOMYCIN
Sponsors
IRCCS Istituto Nazionale Tumori Fondazione Pascale
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the safety and feasibility, Increase in the rate of complete histopathological response in the treatment arm compared to the control arm. | — |
Countries
Italy
Outcome results
None listed